Do you find our website to be helpful?
Yes   No

Lowering Obstetrical Risk with IVF and Preimplantation Genetic Testing

It seems counterintuitive that a couple who has conceived easily, with a family of one or more children, could benefit from IVF.  While this is an uncommon event, it does happen that IVF can be a treatment for a couple with normal fertility but with an obstetrical complication or risk.  

Dr. Moomjy recently published a case study to educate the medical community that IVF permits genetic testing of the embryo, and ultimately can permit selection of an embryo that has a certain genetic marker that makes it a “low risk embryo”.  This case study was of a couple for whom the mother had an antibody that could cross the placenta, bind fetal platelets, and make the baby susceptible to dangerous bleeding prior to delivery. This disease is rare and is called Fetal and Neonatal Alloimmune Thrombocytopenia, or FNAIT. For this couple, the embryonic DNA testing lab, Coopergenomics, was able to customize a DNA test that was able to successfully identify the gene that created platelets that would not bind the maternal antibodies.  The result was a pregnancy with an unaffected fetus, a mother who was relieved to have a pregnancy without invasive diagnostic and therapeutic interventions, and a healthy baby delivered at term, vaginally. While preimplantation genetic testing for a single gene (or monogenic diseases) has been employed for more than 20 years, this was the first published case of using IVF with PGT for this rare disease of FNAIT.  It was the mother who insisted that we publish this case as none of her previous consultants were aware of this option.  This case also demonstrates that with great science, creativity, and individualized care, we can achieve such great outcomes for our patients.

Preimplantation Genetic Testing for a monogenic disorder can prevent live births affected  by fetal and neonatal alloimmune thrombocytopenia,  Shaw J., Blakemore J., Moomjy M., Pediatric Blood and Cancer 2020 0 (#4399792)

Maureen O'Brien Moomjy, MD, FACOG

You Might Also Enjoy...

Fertility Ed 101

When we hear the word fertility, what do we think? How much were we ever taught? How do we manage our own personal fertility questions?

Lessons From COVID-19

The Covid-19 pandemic has affected every citizen of this world. In this post, we aim to highlight lessons we can learn from Covid-19.

Better Living: Avoiding Toxins

With over 80,000 registered chemicals in the United States, it is easy to imagine how we can come in contact with any of them throughout our daily lives. In this post, we aim to highlight the most common chemicals and toxins that we come across regularly.

Endometrial Biopsy: What to Expect

An endometrial biopsy is a small sampling of this tissue done midcycle or later to permit microscopic detailed assessments. Learn more in our latest blog post!